Moreover, the exclusive reliance on NT-proBNP levels for HF diagnosis in recruited patients resulted in enhanced specificity; however, it also might limit generalizability by excluding patients with clinical HF but lower biomarker levels, particularly in HFpEF, where natriuretic peptides can be paradoxically lower. The gene discussed is NPPB; the disease is hydrops fetalis.